CELLINK this week introduced a new addition to its Bioprinter range, with the launch of the new X BIO printer, which will provide tissue engineers with both pneumatic and syringe extrusion technologies in a single system.
CELLINK is the world's first bioink company and is also the creator of the world's first generic bioink, allowing scientists and tissue engineers to bioprint using any type of cell.
For those unfamiliar with the technology, bioink is “a hydrogel biomaterial that is suitable for bioprinting and provides a temporary support for cells while they produce their own extracellular matrix,” explains CELLINK.
BIO X is the new go-to Bioprinter for such companies, researchers and innovators working with bioprinting. Built to meet the needs of today's bioscientists, it responds to specialized computer programs, allowing the user to orchestrate the complex process of building human tissues.
Bioprinting uses 3D printing technology in combination with bioink to create complex 3-dimensional structures. Using bioink, these structures can be fabricated with living cells to create real, living tissue. The technique ensures precision and flexibility when it comes to cell placement and different cell types. technology opens up a wide range of different applications. For example, bioprinting can be used on bone cells, skin cells or tissues for internal organs. These tissues can then be used for oncology research, drug testing, high-throughput drug screening or screening of cosmetic compounds.
